{
  "protocolSection": {
    "identificationModule": {
      "nctId": "NCT04404023",
      "orgStudyIdInfo": {
        "id": "UBP-A124-IgE"
      },
      "organization": {
        "fullName": "UBP Greater China (Shanghai) Co., Ltd",
        "class": "INDUSTRY"
      },
      "briefTitle": "Evaluate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics and Immunogenicity of UB-221 in Healthy Volunteers",
      "officialTitle": "A Phase I, Open-Label, Dose-Escalation Study to Evaluate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics and Immunogenicity of a Single Dose of UB-221 in Healthy Volunteers"
    },
    "statusModule": {
      "statusVerifiedDate": "2022-05",
      "overallStatus": "UNKNOWN",
      "lastKnownStatus": "NOT_YET_RECRUITING",
      "expandedAccessInfo": {
        "hasExpandedAccess": false
      },
      "startDateStruct": {
        "date": "2023-12-01",
        "type": "ESTIMATED"
      },
      "primaryCompletionDateStruct": {
        "date": "2024-06",
        "type": "ESTIMATED"
      },
      "completionDateStruct": {
        "date": "2025-06",
        "type": "ESTIMATED"
      },
      "studyFirstSubmitDate": "2020-05-21",
      "studyFirstSubmitQcDate": "2020-05-21",
      "studyFirstPostDateStruct": {
        "date": "2020-05-27",
        "type": "ACTUAL"
      },
      "lastUpdateSubmitDate": "2022-05-16",
      "lastUpdatePostDateStruct": {
        "date": "2022-05-18",
        "type": "ACTUAL"
      }
    },
    "sponsorCollaboratorsModule": {
      "responsibleParty": {
        "type": "SPONSOR"
      },
      "leadSponsor": {
        "name": "UBP Greater China (Shanghai) Co., Ltd",
        "class": "INDUSTRY"
      }
    },
    "oversightModule": {
      "isFdaRegulatedDrug": false,
      "isFdaRegulatedDevice": false
    },
    "descriptionModule": {
      "briefSummary": "The purpose of the study is to evaluate the safety, tolerability, pharmacokinetics, pharmacodynamics, and immunogenicity of a single dose of UB-221 in healthy volunteers.",
      "detailedDescription": "This is a phase I, open-label, dose-escalation study to evaluate the safety, tolerability, pharmacokinetics, pharmacodynamics,and immunogenicity of a single dose of UB-221 in healthy volunteers."
    },
    "conditionsModule": {
      "conditions": [
        "Chronic Spontaneous Urticaria"
      ]
    },
    "designModule": {
      "studyType": "INTERVENTIONAL",
      "phases": [
        "PHASE1"
      ],
      "designInfo": {
        "allocation": "NON_RANDOMIZED",
        "interventionModel": "SEQUENTIAL",
        "primaryPurpose": "TREATMENT",
        "maskingInfo": {
          "masking": "NONE"
        }
      },
      "enrollmentInfo": {
        "count": 15,
        "type": "ESTIMATED"
      }
    },
    "armsInterventionsModule": {
      "armGroups": [
        {
          "label": "UB-221 (0.2 mg/kg)",
          "type": "EXPERIMENTAL",
          "description": "Intravenous infusion",
          "interventionNames": [
            "Biological: UB-221"
          ]
        },
        {
          "label": "UB-221 (0.6 mg/kg)",
          "type": "EXPERIMENTAL",
          "description": "Intravenous infusion",
          "interventionNames": [
            "Biological: UB-221"
          ]
        },
        {
          "label": "UB-221 (2 mg/kg)",
          "type": "EXPERIMENTAL",
          "description": "Intravenous infusion",
          "interventionNames": [
            "Biological: UB-221"
          ]
        },
        {
          "label": "UB-221 (6 mg/kg)",
          "type": "EXPERIMENTAL",
          "description": "Intravenous infusion",
          "interventionNames": [
            "Biological: UB-221"
          ]
        },
        {
          "label": "UB-221 (10 mg/kg)",
          "type": "EXPERIMENTAL",
          "description": "Intravenous infusion",
          "interventionNames": [
            "Biological: UB-221"
          ]
        }
      ],
      "interventions": [
        {
          "type": "BIOLOGICAL",
          "name": "UB-221",
          "description": "UB-221 (75 mg/ml)",
          "armGroupLabels": [
            "UB-221 (0.2 mg/kg)",
            "UB-221 (0.6 mg/kg)",
            "UB-221 (10 mg/kg)",
            "UB-221 (2 mg/kg)",
            "UB-221 (6 mg/kg)"
          ]
        }
      ]
    },
    "outcomesModule": {
      "primaryOutcomes": [
        {
          "measure": "1.Adverse event incidence",
          "description": "from the baseline to day 15 after IP infusion",
          "timeFrame": "15 days"
        }
      ]
    },
    "eligibilityModule": {
      "eligibilityCriteria": "Inclusion Criteria:\n\n* Subjects with age between 20 to 65 years old (inclusive).\n* Subjects who are able and willing to provide the informed consent.\n* Male subjects with body weight of 50 kilogram (kg) or above; female subjects body weight of 45 kilogram (kg) or above.\n* Researchers based on medical history, physical examination, vital signs, clinical laboratory results and 12-lead electrocardiogram identified healthy subjects without clinically significant abnormalities\n\nExclusion Criteria:\n\nâ€¢ The investigator considered that the subjects were not suitable to participate in this study.",
      "healthyVolunteers": true,
      "sex": "ALL",
      "minimumAge": "20 Years",
      "maximumAge": "65 Years",
      "stdAges": [
        "ADULT",
        "OLDER_ADULT"
      ]
    }
  },
  "derivedSection": {
    "miscInfoModule": {
      "versionHolder": "2026-02-04"
    },
    "conditionBrowseModule": {
      "meshes": [
        {
          "id": "D000080223",
          "term": "Chronic Urticaria"
        }
      ],
      "ancestors": [
        {
          "id": "D014581",
          "term": "Urticaria"
        },
        {
          "id": "D017445",
          "term": "Skin Diseases, Vascular"
        },
        {
          "id": "D012871",
          "term": "Skin Diseases"
        },
        {
          "id": "D017437",
          "term": "Skin and Connective Tissue Diseases"
        },
        {
          "id": "D006969",
          "term": "Hypersensitivity, Immediate"
        },
        {
          "id": "D006967",
          "term": "Hypersensitivity"
        },
        {
          "id": "D007154",
          "term": "Immune System Diseases"
        },
        {
          "id": "D002908",
          "term": "Chronic Disease"
        },
        {
          "id": "D020969",
          "term": "Disease Attributes"
        },
        {
          "id": "D010335",
          "term": "Pathologic Processes"
        },
        {
          "id": "D013568",
          "term": "Pathological Conditions, Signs and Symptoms"
        }
      ]
    }
  },
  "hasResults": false
}